An innovative screening method for coronary heart disease and stroke
CA 2552956 C · Owner: Wang, Xing F. · Inventors: Wang, Xing F.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention is a multiparameter method of screening for the diagnosis, prevention or treatment of atherosclerosis-related coronary heart disease (CHD) or stroke. This method is used for predicting a total risk of the disease and a disease risk level, determining a primary cause in the , disease, assessing a therapeutic efficacy and optimizing the therapeutic targets at different stages of the disease in different individuals who require the therapy to prevent or to treat the disease. This invention can be used to combine the contributions of atherosclerotic risk factors to the disease and to unite the two major methods for diagnosing the disease: screening the Low-density …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed September 27, 2004 and granted January 3, 2017. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended September 27, 2024.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by September 27, 2026.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.